DNTT-mediated DNA Damage Response Drives Inotuzumab Ozogamicin Resistance in B-cell Acute Lymphoblastic Leukemia.
Escherich CS, Moriyama T, Li Z, Hsiao Y, Yang W, Li Y, Reyes N, Walker M, Budhraja A, Bhatara S, Diaz-Flores E, Stock W, Paietta E, Konopleva MY, Kornblau SM, Litzow MR, Inaba H, Pui CH, Opferman JT, Loh ML, Yu J, O'Brien M, Evans WE, Yang JJ.
Escherich CS, et al. Among authors: yu j.
Blood. 2024 Dec 27:blood.2024026085. doi: 10.1182/blood.2024026085. Online ahead of print.
Blood. 2024.
PMID: 39791601